BIAF vs LLY: Which Stock is Better?
Side-by-side comparison of bioAffinity Technologies, Inc. and Eli Lilly and Company in 2026
BIAF
bioAffinity Technologies, Inc.
—
LLY
Eli Lilly and Company
$1188.58
Key Metrics Comparison
| Metric | BIAF | LLY | Winner |
|---|---|---|---|
| Market Cap | $3.95M | $991.62B | LLY |
| P/E Ratio | N/A | 39.47 | LLY |
| EPS (TTM) | $N/A | $N/A | Tie |
| Revenue Growth | 0.0% | 0.0% | Tie |
| Gross Margin | 0.0% | 0.0% | Tie |
Analyze BIAF
Full quant analysis
Analyze LLY
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is BIAF or LLY a better investment?
Comparing BIAF and LLY: bioAffinity Technologies, Inc. has a market cap of $3.95M while Eli Lilly and Company has $991.62B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between BIAF and LLY?
BIAF (bioAffinity Technologies, Inc.) and LLY (Eli Lilly and Company) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: BIAF or LLY?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: BIAF or LLY?
Both BIAF and LLY show similar growth rates. Check our detailed analysis for quarterly trends.
Which company is more profitable: BIAF or LLY?
Both companies show comparable profitability metrics. View the full comparison above for detailed analysis.
Which is the larger company: BIAF or LLY?
Eli Lilly and Company (LLY) is larger with a market cap of $991.62B compared to $3.95M for BIAF.
Should I buy BIAF or LLY in 2026?
Both BIAF and LLY have investment merit. BIAF trades at $N/A while LLY trades at $1188.58. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between BIAF and LLY stock?
Key differences: Market Cap ($3.95M vs $991.62B), P/E Ratio (N/A vs 39.5x), Revenue Growth (0.0% vs 0.0%), Gross Margin (0.0% vs 0.0%).
Should I buy BIAF or LLY in 2026?
The choice between BIAF and LLY depends on your investment goals. LLY shows higher revenue growth (0.0%). LLY has better margins (0.0%). Consider your risk tolerance and time horizon.
What is the market cap comparison between BIAF and LLY?
BIAF (bioAffinity Technologies, Inc.) has a market cap of $3.95M, while LLY (Eli Lilly and Company) has a market cap of $991.62B. LLY is the larger company by market value.